We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
-12.75%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$258M
AUM Growth
-$43.5M
Cap. Flow
+$1.68M
Cap. Flow %
0.65%
Top 10 Hldgs %
39.65%
Holding
62
New
5
Increased
16
Reduced
5
Closed
8

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.65M
2
FISV
Fiserv Inc
FISV
+$5.9M
3
TSLA icon
Tesla
TSLA
+$2.56M
4
BDX icon
Becton Dickinson
BDX
+$2.53M
5
ABT icon
Abbott
ABT
+$2.39M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$7.51M
2
AVGO icon
Broadcom
AVGO
+$5.79M
3
IPGP icon
IPG Photonics
IPGP
+$5.23M
4
AEO icon
American Eagle Outfitters
AEO
+$1.99M
5
PFE icon
Pfizer
PFE
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 26.59%
2 Technology 19.47%
3 Industrials 15%
4 Communication Services 10.95%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
26
Home Depot
HD
$332B
$4.48M 1.74%
24,000
– –
MMM icon
27
3M
MMM
$83B
$3.82M 1.48%
33,488
– –
WMT icon
28
Walmart Inc
WMT
$893B
$3.75M 1.46%
99,000
– –
ALC icon
29
Alcon
ALC
$34.2B
$3.5M 1.36%
68,808
+800
+1% +$46K
CL icon
30
Colgate-Palmolive
CL
$73.6B
$3.4M 1.32%
51,200
– –
MRK icon
31
Merck
MRK
$307B
$3.21M 1.25%
43,702
-20,960
-32% -$1.65M
SYK icon
32
Stryker
SYK
$122B
$3.19M 1.24%
19,145
– –
LOW icon
33
Lowe's Companies
LOW
$115B
$2.98M 1.16%
34,600
– –
ZTS icon
34
Zoetis
ZTS
$31.9B
$2.92M 1.13%
24,818
– –
ADBE icon
35
Adobe
ADBE
$93.3B
$2.86M 1.11%
9,000
– –
CMCSA icon
36
Comcast
CMCSA
$84.9B
$2.68M 1.04%
78,000
– –
GOOG icon
37
Alphabet (Google) Class C
GOOG
$4.29T
$2.62M 1.02%
45,120
– –
RTN
38
DELISTED
Raytheon Company
RTN
$2.62M 1.02%
20,000
– –
BDX icon
39
Becton Dickinson
BDX
$42.6B
$2.3M 0.89%
+10,250
New +$2.53M
TSLA icon
40
Tesla
TSLA
$1.39T
$2.16M 0.84%
+61,785
New +$2.56M
CSX icon
41
CSX Corp
CSX
$93.1B
$1.95M 0.76%
102,000
– –
PFE icon
42
Pfizer
PFE
$141B
$1.58M 0.61%
51,119
-49,538
-49% -$1.69M
PEP icon
43
PepsiCo
PEP
$185B
$1.56M 0.61%
13,000
– –
APH icon
44
Amphenol
APH
$185B
$1.46M 0.57%
+80,080
New +$1.91M
XOM icon
45
ExxonMobil
XOM
$615B
$1.18M 0.46%
31,040
– –
T icon
46
AT&T
T
$153B
$1.17M 0.45%
52,960
– –
CI icon
47
Cigna
CI
$75.1B
$1.03M 0.4%
5,841
– –
IFF icon
48
International Flavors & Fragrances
IFF
$19.7B
$1.02M 0.4%
10,000
– –
FTV icon
49
Fortive
FTV
$18.6B
$1M 0.39%
28,782
– –
CNI icon
50
Canadian National Railway
CNI
$76.9B
$780K 0.3%
10,050
+925
+10% +$80.6K
1
2
3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $618M AUM 60.79% 1-Year Est. Return

Chad R. Baker's Q1 2020 Portfolio in Review

As of Q1 2020, Chad R. Baker held 62 positions worth $258M, down 14% from $301M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Chad R. Baker's Q1 2020 filing shows 5 new, 16 increased, 5 reduced and 8 closed positions. Its largest new stake was Microsoft: 52,625 shares worth $8.3M. The largest sale was Boston Scientific, an estimated $7.51M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.

  • Chad R. Baker's largest Q1 2020 buy was Microsoft: 52,625 shares worth $8.3M.
  • Chad R. Baker added most to Abbott in Q1 2020, an estimated $2.39M increase.
  • Chad R. Baker's biggest Q1 2020 reduction was Pfizer, cutting an estimated $1.69M.
  • Chad R. Baker fully exited Boston Scientific in Q1 2020, selling an estimated $7.51M.
  • Chad R. Baker's ten largest holdings make up 40% of its $258M portfolio in Q1 2020.
  • Chad R. Baker opened 5 new positions and closed 8 in Q1 2020.
  • Chad R. Baker's portfolio value fell 14% quarter-over-quarter to $258M.

Based on Chad R. Baker's 13F filing for Q1 2020, filed 1 May 2020.